NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,930 | +17.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $12,725 | -5.1% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $13,415 | -22.8% | 10,000 | -9.1% | 0.00% | – |
| Q4 2022 | $17,367 | +2.2% | 11,000 | -8.3% | 0.00% | – |
| Q3 2022 | $17,000 | +88.9% | 12,000 | +71.4% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -11.1% | 7,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +800.0% | 7,000 | +600.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |